As of November 6, 2026, Simulations Plus, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from June 17, 2026 to October 6, 2026 (Form 8-K, October 6, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Simulations Plus, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Simulations Plus, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-06-17 to 2026-10-06. Every row below is cited to the filing it comes from, and this page adds each new change as Simulations Plus, Inc. files it.
Also on the record for Simulations Plus, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 6, 2026 | Acquired by SP Evolution HoldCo II, LLC | $376.80M | Acquisition | Source |
| August 6, 2026 | Stake report, Schedule 13G, by First Eagle Investment Management, LLC | 5.3% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 6, 2026 | Stake report, Schedule 13G, by First Light Asset Management, LLC | 13.15% of the class | 5%+ stakes | Source |
| January 30, 2026 | Stake report, Schedule 13G, by The Vanguard Group | 5.02% of the class | 5%+ stakes | Source |
| October 30, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 4.84% of the class | 5%+ stakes | Source |
| October 2, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 5.8% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Simulations Plus, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Simulations Plus, Inc. and the records around it.
Simulations Plus, Inc. elsewhere on the record
- Acquisition Oct 2026
- Who owns it
Companies that share a holder
- First Light Asset Management, LLC also filed stake reports on 12 other companies: NeuroPace Inc (Sep 2026), Neogenomics, Inc. (Aug 2026), PALVELLA THERAPEUTICS, INC. (Aug 2026)
- First Eagle Investment Management, LLC also filed stake reports on 16 other companies: AMTECH SYSTEMS INC (Aug 2026), DENTSPLY SIRONA Inc. (Aug 2026), Quanterix Corp (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Simulations Plus, Inc.
Get an email when Simulations Plus, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Simulations Plus, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Simulations Plus, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Simulations Plus, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-10-06 | Reported | not named in the filing | 8-K, 2026-10-06 | ||
| 2026-06-17 | Reported | not named in the filing | 8-K, 2026-06-17 |
New leaders reset buying decisions — get the Full Report on Simulations Plus, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Simulations Plus, Inc., with the record behind each one.
Find candidates like senior executive at Simulations Plus, Inc.Every change, in the filing's words
Reported
Pursuant to the terms of the Merger Agreement, at the Effective Time, each of Dr. Daniel Weiner, Dr. Walter S. Woltosz, Dr. John K. Paglia and Sharlene Evans ceased serving as a member of the Board of Directors of the Company (the " Board ") and on any and all committees of the Board on which they served.
- At the Effective Time, Matteo Foderaro and Charles Mullens became the directors of the Surviving Corporation.
- Pursuant to the Merger Agreement, the officers of the Company at the Effective Time continued as the officers of the Surviving Corporation.
- On October 6, 2026, following the consummation of the Merger, the Board appointed Paul Labute as President of the Company.
- Additionally, in connection with the consummation of the Merger, pursuant to the terms of the Merger Agreement, the Company's 2021 Equity Incentive Plan, as amended (the "Company Equity Plan"), was terminated at or prior to the Effective Time.
Reported
Such risks and uncertainties include, among others: (i) the timing to consummate the proposed Merger; (ii) the risk that a condition to closing of the proposed Merger may not be satisfied or waived or that the closing of the proposed Merger might otherwise not occur; (iii) the risk that required regulatory approvals for the proposed Merger are not obtained, are delayed or are obtained subject to unexpected conditions; (iv) the occurrence of any event, change or other circumstance that could give rise to the termination of the Merger Agreement, including in circumstances requiring the Company t
- On June 15, 2026, the Company's Compensation Committee of the Board approved a transaction bonus program for certain employees of the Company, including certain executive officers, in recognition of the anticipated additional responsibilities associated with supporting the proposed transaction.
- Under the transaction bonus program, eligible participants will receive a cash payment upon the consummation of the Merger contemplated by the Merger Agreement, subject to satisfaction of the terms and conditions of the program.
- The following Named Executive Officers are eligible to receive the following transaction bonus amounts upon the closing of the Merger: Named Executive Officer Transaction Bonus Shawn O'Connor, Chief Executive Officer $822,000 William Frederick, EVP and Chief Financial Officer $539,000 John DiBella, Chief Revenue Officer $269,000 Jill Fiedler-Kelly, President, Services Solutions $251,000 Joshua Fohey, Chief Operating Officer $212,000 In addition to the named executive officers listed above, certain other employees are eligible to participate in the transaction bonus program.
- The aggregate amount payable to all participants, including the named executive officers listed above, is approximately $3.114 million.
Tools for this story
Each opens in a new tab, filled in for Simulations Plus, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.